ResearchMoz added Latest Research Report titled " Enteral Nutrition Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 " to it's Large Report database.
Enteral Nutrition Pumps also known as enteral feeding pumps are used to deliver nutritious foods containing carbohydrate, protein, fat, vitamin, minerals and water by inserting directly into the stomach or parts of small intestine. Enteral nutrition pumps are recommended to patients suffering from gastrointestinal tract disorders, malnourished patients or those who are at high risk of malnutrition, and patients with chronic diseases such as diabetes, cancer and AIDS who are unable to maintain an optimal nutritional level orally.
The global market for enteral nutrition pumps has been segmented into portable enteral nutrition pumps and stationary enteral nutrition pumps on the basis of product type. Of these two major types, portable enteral nutrition pumps are in greater demand across the globe and are expected to witness significant market growth during the forecast period from 2014 to 2020. EnteraLite Infinity marketed by Moog, Inc. and the Kangaroo Joey enteral feeding pump by Covidien plc are the commercially available enteral nutrition pumps that are highly portable and light in weight. On the basis of end use, the global enteral nutrition pumps market is segmented into hospitals, physician offices, ambulatory care centers and home care.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=240146
Globally increasing elderly population coupled with rising preference of home enteral therapy have been identified as the major factors driving the market for home based enteral nutrition pumps market. According to the Population Division of United Nations Department of Economic and Social Affairs, the world is witnessing a continuous increase in the population share of people aged 60 years or over as compared to children and adults aged below 60 years, over the past few decades. It is mainly due to decreased mortality rate owing to improved healthcare infrastructure and declining fertility. The United Nations Department of Economic and Social Affairs reveals that the global population share of people aged 60 years and over has increased from 9.2% in 1990 to 11.7% in 2013 and is expected to reach approximately 21.1% by the end of 2050. In addition, introduction of International Organization for Standardization (ISO) and rising cases of preterm birth that demands feeding by enteral nutrition pumps are the factors accentuating the growth of this market during the forecast period from 2014 to 2020.
Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html
Globally increasing incidence and prevalence of people suffering from chronic illnesses such as cancer, diabetes, AIDS, neurological and gastrointestinal disorders, rising awareness level regarding the enteral nutrition pumps and increasing need of reconstructive surgeries coupled with technological advancements in these devices are expected to widen the market for enteral nutrition pumps. According to the National Center for Health Statistics (NCHS) Home Survey, approximately 30,700 patients in long-term care facilities are on home enteral nutrition and receive pump feeding every year. Additionally, these devices have also gained widespread popularity because manufacturers are constantly coming up with new and innovative devices that are easy to use and have few complications. For example, these devices are now equipped with battery packs. On the other hand, factors such as complications associated with the enteral nutritious food delivery such as diarrhea, gastrointestinal complications, and non-obstructive intestinal ischemia along with the stringent reimbursement policies are expected to restrict the growth of enteral nutrition pumps market to some extent.
Abbott Nutrition, ALCOR Scientific, Covidien plc, Moog, Inc., B. Braun Melsungen AG and Fresenius Kabi are among the key players operating in the market for enteral nutrition pumps.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Wheelchair Accessible Vehicle Converters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 " to it's Large Report database.
Vehicles which are converted in a way that have easy access for wheelchairs are termed as Wheelchair Accessible Vehicles or WAV’s. The vehicles are specially converted from a standard vehicle to WAV in order to accommodate the wheelchair. Wheelchair accessible vehicles are considered as multipurpose vehicle as it can be used for medical as well as general purpose. The important aspect of wheelchair accessible vehicle is that patient can travel while remaining in their wheelchair, either as a passenger or driver. The common feature that are associated with most of the wheelchair accessible vehicle includes a built-in ramp, access from the side or the back of the vehicle, a lowered floor or raised roof to allow enough headroom and wheelchair tie-downs. There are three different sizes of wheelchair accessible vehicles available in the market namely small, medium and large. Small WAVs usually have a ramp rather a lift and it can accommodate up to four people including a wheelchair passenger/patient.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=240147
Likewise, larger wheelchair requires medium sized WAVs. Large WAVs can carry a number of passengers along with the wheel chair patient. The following common conversions are involved in a wheelchair accessible vehicle: seating is modified to allow wheelchair access, suspension may be stiffened to allow extra weight of power chairs, gas tanks and fuel lines may be modified and floor of the vehicle is lowered. It is mandatory that all the wheelchair accessible vehicles should be certified by National Highway Traffic Safety Administration (NHTSA) regulations.
The global market for wheelchair accessible vehicle converters is growing at a rapid pace worldwide primarily due to technological advancement and growing demand of quality and safe healthcare services by the patient. Moreover, rapidly rising incidences of car and bike accidents is also eventually accentuating the global market demand of wheelchair accessible vehicle converters. Car and bike accident are the common cause for orthopedic trauma across the world. Nearly 1.24 million deaths occur due to traffic accident in every year globally stated by World Health Organization.
Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html
Moreover, fatal and non-fatal accident is on the rise globally and it will accentuate the global wheelchair accessible vehicle converters market. However, high cost and lack of medical reimbursement are considered as market restraining factor in the global wheelchair accessible vehicle converters market. It is expected that Asian countries would experience immense potential in the wheelchair accessible vehicle converters market during the study period.
North America and Europe dominates the global market of wheelchair accessible vehicle converters due to extensive technological advancement and rising prevalence of various orthopedic surgeries. Furthermore, favorable government initiatives would also drive the wheelchair accessible vehicle converters market in North America and Europe. Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure. Hence, it is expected that Asian market will experience a tremendous growth during the study period. Rest of the world (RoW) holds fourth position in the global wheelchair accessible vehicle converters market due to poor economic and health condition in most of the African countries.
Some of the key players operating in the global wheelchair accessible vehicle converters market includes Fiat Doblo, Renault Kangoo, Kia Sedona and Skoda Roomster, Grand Voyager and Peugeot Bipper.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products " to it's Large Report database.
Fatty liver disease (FLD) comprises a spectrum of chronic liver disorders characterized by excessive lipid accumulation in the liver (steatosis), which may lead to inflammation (steatohepatitis) and fibrosis. It has the potential to progress to end-stage liver diseases such as cirrhosis, liver cancer and liver failure, and is also associated with numerous complications and co-morbidities, including cardiovascular and metabolic diseases. FLD can be divided into non-alcoholic FLD (NAFLD) and alcoholic FLD (AFLD), depending on the patent’s history of alcohol use.
FLD is the most common chronic liver disease in the world, and its global prevalence has increased rapidly in the past several decades. The worldwide prevalence of FLD is estimated at 20–45% in the general population, and up to 90% in obese patients. There is a broad consensus to describe the condition as the hepatic manifestation of metabolic syndrome, and it is closely associated with obesity, diabetes and dyslipidemia. NAFLD has become the main driver of the rapid growth of FLD prevalence, mainly due to the rising prevalence of obesity.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1065937
FLD is increasingly recognized as a major global health problem. However, despite this the FLD market is still in its infancy, with no FDA-approved drugs for this indication, and only a limited number of generic drugs approved in non-US markets in recent years.
Due to the increasing health burden of FLD and the lack of therapeutic options, there is a pressing need to develop pharmacological strategies. This is especially the case for patients with steatohepatitis, who are at the greatest risk of developing cirrhosis or liver cancer, which can lead to liver failure. Due to the pathophysiological complexity of FLD and its diverse population, different therapeutic agents are likely to be needed to tackle the lipotoxicity, inflammation and fibrogenesis that drive FLD progression.
FLD has an active pipeline and first-in-class products account for a considerable proportion, which is very promising considering the level of unmet need and lack of approved treatment options. First-in-class innovation is concentrated heavily at the early drug development stages, and prominent first-in-class molecular targets include nuclear receptors, immune mediators, and molecules involved in lipid synthesis. Additionally, the first-in-class targets identified show considerable diversity, reflecting the multifaceted aspects of FLD pathophysiology.
Read All Diseases & Conditions Market Research Reports @ http://www.researchmoz.us/diseases-conditions-market-reports-67.html
Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Executive Summary 5
2.1 Urgent Unmet Need Driven By Rising Prevalence 5
2.2 High Degree of First-in-Class Innovation 5
2.3 Rising Deal Volumes and Considerable Investment Opportunities in First-in-Class Product Development 5
3 The Case for Innovation 6
3.1 Growing Opportunities for Biologic Products 7
3.2 Diversification of Molecular Targets 7
3.3 Innovative First-in-Class Development Remains Attractive 7
3.4 Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation 8
3.5 Sustained Innovation 8
3.6 GBI Research Report Guidance 8
4 Clinical and Commercial Landscape 10
4.1 Disease Overview 10
4.2 Disease Symptoms 11
4.3 Epidemiology 11
4.4 Etiology and Risk Factors 11
4.4.1 Environmental Factors 11
4.4.2 Host Factors 12
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Pharmaceutical Lifecycle Management Strategies in 2017 " to it's Large Report database.
GBI Research’s latest report, ""Pharmaceutical Lifecycle Management Strategies in 2017"" provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world. The pharmaceutical industry remains highly competitive and lucrative, and companies are investing significant time and resources into implementing strategies aimed at preserving the revenue streams of their products by extending patent life, delaying competition or slowing the pace of revenue loss following the end of market exclusivity.
The study, delivered in the form of an 82-slide PowerPoint presentation investigates a wide range of commercial, developmental, legal and regulatory strategies. This report format allows you to easily assemble high-quality presentations and research material to meet a variety of corporate requirements. Our research deep dives into the rationale for implementing LCM strategies, as well as the challenges, risks and commercial opportunities they represent. Moreover, detailed case studies showcasing recent real-world examples of LCM strategies will enable understanding of the key factors that determined their success. Information leveraged from our robust industry-leading database also highlights strategies being implemented for products currently in development.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1065938
The pharmaceutical industry will continue to face a wide range of challenges in the coming years, including patent cliffs, declining productivity, intensifying levels of competition from generic and biosimilar manufacturers, low reimbursement levels and stricter regulatory policies. Careful LCM planning will continue to be a crucial element of the industry’s ability to answer these problems.
GBI Research conducted extensive research to provide a comprehensive understanding of the LCM strategies being implemented by players in the pharmaceutical industry. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.
Scope
- What is driving the need for effective LCM strategies in the pharmaceutical industry?
- What are the most common LCM strategies being implemented?
- What are the business opportunities and commercial rewards arising from the implementation of LCM strategies?
- What are the key factors that impact the choice of LCM strategy?
- What strategies have Big Pharma companies implemented in recent years to preserve revenues and market share?
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of contents
1. Introduction
2. Executive Summary
3. Introduction to Pharmaceutical Lifecycle Management Strategies
3.1 The Pharmaceutical Product Lifecycle Curve
3.2 Key Objectives of Life Cycle Management Strategies in the
Pharmaceutical Industry
3.3 What is Driving the Need for Effective Lifecycle Management
Strategies in the Pharmaceutical Industry?
3.4 Classification and Benefits of Different Lifecycle Management
Strategies for Pharma
3.5 Business Opportunities Created by LCM Strategies
3.6 Factors Impacting Choice of Lifecycle Strategies
4. Pharmaceutical Lifecycle Management – Commercial Strategies
4.1 Rx-to-OTC Switch as an LCM Strategy
4.1.1 RX-to-OTC Switch Case Studies
4.2 Geographical Expansion
4.3 Contract Research Organizations Helping Overcome Industry Challenges
4.3.1 Benefits from Partnering with Contract Development and
Manufacturing Organizations (CDMOs)
4.3.2 Strategic Partnerships with CROs: Case studies
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology and Market Forecast-2023 " to it's Large Report database.
DelveInsight’s “Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023” Report provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan, as well as rest of Europe (RoE) and rest of the world (RoW). The Report covers the therapeutics market revenue, treatment practice and Chemotherapy Induced Neutropenia (CIN) forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report provides the historical and forecasted data of incident cases at risk of Chemotherapy Induced Neutropenia (CIN) in 10 Cancer indications till 2023.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1045347
The report covers the number of patients for 10 cancer indications (i.e. Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian Cancer, Hodgkin’s disease and Non-Hodgkin Lymphoma), who are at risk of developing CIN as an adverse event of the chemotherapies of respective cancers. Neupogen (Filgrastim), developed and marketed by Amgen is the first G-CSF approved for chemotherapy-induced neutropenia (CIN) in 1991. Its PEGylated formulation, Neulasta was later approved in 2002. Filgrastim i.e., Neupogen and PEGylated filgrastim (Neulasta) contribute
to majority of the market size, of CIN. However, New Chemical Entities are expected to launch in the near future. According to DelveInsight, the Global Market size of CIN in 2016 was USD 3.67 Billion.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Content
Report Introduction
Chemotherapy Induced Neutropenia (CIN) Market Overview at a Glance
Global Market Size of CIN in 2016
Global Market Size of CIN in 2023
Chemotherapy Induced Neutropenia (CIN)
Overview
Causes of Neutropenia
Common cycle of chemotherapy-related neutropenia
Signs and symptoms
Risk Factors
Severity and Grades of Neutropenia
Pathophysiology/ Mechanisms of action
Diagnosis
Epidemiology and Patient Population
Assumptions and Caveats
United States
Incident Cases of ten major Cancer indications in United States
Incident Cases of Chemotherapy Induced Neutropenia based on ten major Cancer
indications in United States
Ten major cancer patients at low risk of CIN in United States
Ten major cancer patients at intermediate to high risk of CIN in United States
Europe
Germany
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023 " to it's Large Report database.
DelveInsights Colorectal cancer - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market size of the Colorectal Cancer (CRC) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed cases of Colorectal Cancer (CRC) from 2013-2023. According to DelveInsight, the 7MM Diagnosed cases for Colorectal Cancer are expected to increase, with total 514,148 cases in 2023.
According to DelveInsight, the 7 MM market size of Colorectal Cancer market is estimated to be USD 11682 million by 2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1065649
Key Coverage and Benefits:
The report will help in developing business strategies by understanding the trends shaping and driving the global Colorectal Cancer market.
Organize sales and marketing efforts by identifying the best opportunities for Colorectal Cancer in US, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
To understand the future market competition in the global Colorectal Cancer market and Insightful review of the key market drivers and barriers.
The Report also covers the detailed global historical and forecasted Colorectal Cancer market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Content
Report Introduction
Colorectal Cancer Market Overview at a Glance
Global Market Size of Colorectal Cancer (2013-2023)
7 MM Market Size of Colorectal Cancer (2013-2023)
Total Market Share Distribution of Colorectal Cancer for 7 MM in 2016
Total Market Share Distribution of Colorectal Cancer for 7 MM in 2023
Colorectal Cancer
Overview
Stages
Pathophysiology
Etiology
Risk Factors
Diagnosis
Treatment
Epidemiology and Patient Population
Total number of cases 7MM Countries (2016 & 2023)
United States
Diagnosed Cases of Colorectal Cancer in United States
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
Germany
Diagnosed Cases of Colorectal Cancer in Germany
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
France
Diagnosed Cases of Colorectal Cancer in France
Diagnosed Cases of Colorectal Cancer by Stages
Diagnosed Cases of Colorectal Cancer by Site
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
ResearchMoz added Latest Research Report titled " Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) - By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa) " to it's Large Report database.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).
Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1048255
According to Azoth Analytics research report, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.
Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1 Focus on marketing ADCs at lower cost in Asia Pacific region
3.2 Multiple Licensing and Collaboration
3.3 Outsourcing of ADC manufacturing to CMOs
4. Antibody Drug Conjugates Product Overview
5. Global Antibody Drug Conjugates Market: Growth and Forecast
5.1 By Value (2012-2016)
5.2 By Value (2017-2022)
6. Global Antibody Drug Conjugates Market: By Drug (Adcetris, Kadcyla)
6.1 Global Antibody Drug Conjugates Market-By Drug: Breakdown (%)
6.1.1 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2016
6.1.2 Global Antibody Drug Conjugates Market Size and Share, By Drug, 2022
6.2 Global Adcetris Market Overview
6.2.1 By Value (2012-2016)
6.2.2 By Value (2017-2022)
6.3 Global Kadcyla Market Overview
6.3.1 By Value (2013-2016)
6.3.2 By Value (2017-2022)
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
